Paksoy provides strategic advice to global clients on both cross-border transactions and domestic investments across a wide range of sectors and represents, through specialised sector groups, a spectrum of clients from strategic players to a variety of financial investors, including prominent domestic and international private equity houses.
We work on diverse investment structures including full acquisitions, minority investments, mergers, spin-offs, joint ventures and asset deals.
We have substantial expertise to assist our clients on M&A transactions across a range of non-regulated and regulated sectors, and to accompany them throughout the specificities of regulatory approval processes in Turkey.
Related persons
“ Paksoy's representation of diverse foreign entities on acquisitions further confirms its prominent status in the market. ”
Legal 500
Featured publications
Content not found.
Related contents
11 November 2020
Paksoy advises Telus International on the acquisition of Lionbridge’s artificial intelligence business
Telus International, a world-leading communications and information technology company which delivers next-generation digital solutions for…
16 October 2020
LexisNexis Cross-Border Joint Venture and Strategic Alliance Guide (Turkey)
Our latest publication “Cross-Border Joint Venture and Strategic Alliance Guide (Turkey)” by Togan Turan and Nihan Bacanak is published on…
13 August 2020
Paksoy advises Imerys on the acquisition of a majority stake in the Haznedar group
Imerys, a world leader in mineral-based specialty solutions for the industry, signed a share purchase agreement on 7 August 2020 through…
20 May 2020
Public Mergers and Acquisitions
Turkey chapter of Public Mergers and Acquisitions written by Togan Turan, Ökkeş Şahan and Nazlı Bezirci is published by Thomson Reuters…
7 May 2020
Paksoy advises I Squared Capital on its acquisition in Rubis Terminal Petrol
I Squared Capital LLP, a leading global infrastructure investor, acquired indirectly 45% of the shares in Rubis Terminal held by Rubis.
17 February 2020
Paksoy advises Novartis on the sale of Sandoz Turkey’s manufacturing facility to Generica
Novartis, one of the world’s largest pharmaceutical companies, has executed an agreement to sell one of Sandoz Turkey’s manufacturing…